Categories Trump Innovent Releases Results of a Phase 3 Clinical Study of Tafolecimab(IBI306)in Chinese Patients with non- Familial Hypercholesterolemia at the American Heart Association (AHA) Scirntific Sessions 2022 – Yahoo Finance Post author By Admin Post date November 6, 2022 Listen to this article Innovent Releases Results of a Phase 3 Clinical Study of Tafolecimab(IBI306)in Chinese Patients with non- Familial Hypercholesterolemia at the American Heart Association (AHA) Scirntific Sessions 2022 Yahoo Finance ← Adam Kinzinger Condemns Pro-Trump Christian Event as ‘Mass Delusion’ – Newsweek → Viking Wrestling Begins Season at Yellow Jacket Open – Augustana College Vikings